Skip to content

Clinical trials

Phase 3 Seizures trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 3 Country / region: Russia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20061
20073
20082
20091
20101
20111
20122
20132
20161
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Eisai Inc.2
Marinus Pharmaceuticals2
Novartis Pharmaceuticals2
UCB Pharma2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Population Health Research Institute1
UCB Biopharma S.P.R.L.1
Valexfarm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures21
Epilepsy16
Epilepsies, Partial7
Tuberous Sclerosis2
Angiomyolipoma1
Astrocytoma1
Blood Loss, Surgical1
Epilepsy, Complex Partial1
Epilepsy, Tonic-Clonic1
Hemorrhage1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.